InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 196931

Monday, 11/17/2014 1:44:24 PM

Monday, November 17, 2014 1:44:24 PM

Post# of 345995
Scott Antonia : Peregrine Pharmaceuticals KOL :

Moffitt Cancer Center Applauds Medicare Coverage Decision on Lung Cancer Screening

Nov 11, 2014


“Patients whose tumors are caught early often have better outcomes. Now we have a screening test that can save lives and will be accessible to those at high risk for developing lung cancer,” said Scott J. Antonia, M.D., Ph.D., chair of the Thoracic Oncology Department at Moffitt. “At Moffitt, our comprehensive lung screening program evaluates each CT screening and develops a personalized treatment plan as needed.”

http://moffitt.org/home/moffitt-in-the-news/press-releases/2014/cms-lung-screening


"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News